Retrospective Cohort Study
Copyright ©The Author(s) 2023.
World J Diabetes. Jul 15, 2023; 14(7): 1091-1102
Published online Jul 15, 2023. doi: 10.4239/wjd.v14.i7.1091
Table 2 Characteristics of quality-of-care score of patients with type 2 diabetes mellitus
n (%)
P value
Total, n = 7351
Score ≤ 1, n = 3858
1 < score < 5, n = 2819
Score ≥ 5, n = 674
Age (mean ± SD)55.96 ± 11.9457.08 ± 12.7054.99 ± 10.9453.62 ± 10.70< 0.0001
≤ 40643 (8.8)330 (8.6)245 (8.7)68 (10.1)< 0.0001
40 < age ≤ 654886 (66.5)2369 (61.4)2022 (71.7)495 (73.4)
> 651822 (24.8)1159 (30.0)552 (19.6)111 (16.5)
Sex
Male3963 (53.9)2146 (55.6)1477 (52.4)340 (50.5)< 0.01
Female3388 (46.1)1712 (44.4)1342 (47.6)334 (49.6)
Duration of diabetes mellitus (mean ± SD)9.95 ± 1.949.76 ± 2.0610.14 ± 1.8110.32 ± 1.60< 0.0001
≤ 5 yr216 (2.9)161 (4.2)52 (1.8)3 (0.5)< 0.0001
> 5 yr7135 (97.1)3697 (95.8)2767 (98.2)671 (99.6)
Anti-diabetic drugs
Oral only4729 (64.3)2483 (64.4)1818 (64.5)428 (63.5)< 0.0001
Insulin only1607 (21.9)919 (23.8)608 (21.6)80 (11.9)
Oral + insulin1015 (13.8)456 (11.8)393 (13.9)166 (24.6)
Adherence to medication (%)
< 905340 (72.6)3087 (80.0)1872 (66.4)381 (56.5)< 0.0001
90 ≤ adherence < 1101698 (23.1)637 (16.5)786 (27.9)275 (40.8)
≥ 110313 (4.3)134 (3.5)161 (5.7)18 (2.7)
Comorbidity (DCSI)
04904 (66.7)2444 (63.4)1951 (69.2)509 (75.5)< 0.0001
11160 (15.8)634 (16.4)436 (15.5)90 (13.4)
2911 (12.4)546 (14.2)313 (11.1)52 (7.7)
3227 (3.1)131 (3.4)82 (2.9)14 (2.1)
4122 (1.7)80 (2.1)34 (1.2)8 (1.2)
≥ 527 (0.4)23 (0.6)3 (0.1)1 (0.2)
Hypertension/dyslipidemia
None4782 (65.1)2458 (63.7)1845 (65.5)479 (71.1)< 0.0001
Hypertension only1861 (25.3)1054 (27.3)669 (23.7)138 (20.5)
Dyslipidemia only265 (3.6)124 (3.2)118 (4.2)23 (3.4)
Both443 (6.0)222 (5.8)187 (6.6)34 (5.0)
Acute myocardial infarction event
No7043 (95.8)3666 (95.0)2716 (96.4)661 (98.1)< 0.001
Yes308 (4.2)192 (5.0)103 (3.7)13 (1.9)
Incidence rate (per 1000 person-year)4.215.13.61.87